Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverter defibrillator recipients: Results from a nationwide study

https://doi.org/10.1016/j.jpsychores.2019.03.006Get rights and content

Highlights

  • The prevalence of anxiety and depression is high in ICD recipients.

  • It is high particularly those with the highest levels of multi-morbidity burden.

  • Higher levels of multi-morbidity burden predict worse QOL in ICD recipients.

Abstract

Background

The prevalence of multi-morbidity in implantable cardioverter defibrillator (ICD) recipients is approximately 25%. Multi-morbidity is associated with poor health and psychological outcomes in this population and may affect ICD recipients' quality-of-life (QOL). The purpose of this study was to determine the prevalence of psychological distress (anxiety, depressive symptoms, and Type-D personality) in ICD recipients with varying levels of comorbidities, and to examine the association between multi-morbidity burden and QOL in this population.

Methods

All adults listed in the Swedish ICD and Pacemaker Registry in 2012 with an ICD implanted for at least one year were invited to participate in this study. Binary logistic regression was used to predict QOL using the EQ-5D mean index dichotomized based on median QOL scores. Multi-morbidity burden scores were based on quartile groupings.

Results

A total of 2658 ICD recipients participated in the study (with a mean age of 65, 20.6% female, mean implant duration of 4.7 years, with 35.4% implanted for primary prevention of sudden cardiac arrest). Greater multi-morbidity burden, female sex, not working outside the home, history of ICD shock, negative ICD experience, higher levels of ICD-related concerns, and the presence of anxiety, depression, or Type D personality were associated with worse QOL in ICD recipients. Predictors differed by multi-morbidity burden level.

Conclusions

Multi-morbidity burden and psychological distress is an essential factor related to QOL. This issue should be discussed with potential ICD recipients prior to implant. Further exploration of increased recognition and treatment of psychological distress in ICD recipients is warranted.

Introduction

Implantable cardioverter defibrillators (ICDs) are the first line therapy for individuals at higher risk for or with a prior history of ventricular arrhythmias [[1], [2], [3]]. The ICD is utilized for both primary and secondary prevention of sudden cardiac arrest, particularly in the context of heart failure [[4], [5], [6]]. According to the most recent global survey by the World Society of Arrhythmias, 222,407 new ICDs were implanted and 105,620 devices were replaced in 2009, the most recent year for which international data is available [7].

The prevalence of multi-morbidity in the ICD population is approximately 25% [8]. Multi-morbidity is defined in the literature as two or more significant medical conditions unrelated to the index condition [9,10]. Although multi-morbidity is defined by the existence of a number of chronic disease processes, it is not merely the sum of these diseases. Different conditions have varying levels of associated burden, but the negative effects of chronic illness are compounded by the addition of further comorbidities, increasing the level of disability and healthcare utilization [11]. The prevalence of multi-morbidity in ICD recipients has not been well studied. Reports of the prevalence of multi-morbidity in the general population have varied from 13 to 80% based upon the definition of multi-morbidity used by the researchers [9,10]. Multi-morbidity is associated with poor health outcomes in the ICD population [12,13]. This association between illness burden and poor health outcomes may affect ICD recipients' quality-of-life (QOL) and psychological responses to having an implanted device [8,14,15].

The links between individual chronic illnesses, QOL, and psychological response have been well studied, particularly in cardiovascular disease. However, models may not be generalizable to ICD recipients due to the complexity of implant indications and the existence of multiple comorbidities. ICD implantation occurs in individuals with multi-morbidities, yet little is known about the prevalence of multi-morbidity in ICD recipients and the often-complex interactions between ICDs and other chronic diseases on the psychological responses of this population. Therefore, the overall aim of this study was to determine the prevalence of anxiety and depressive symptoms, Type-D personality, and ICD-related concerns (e.g. worries about battery depletion or limitations due to therapy) in ICD recipients with varying levels of comorbidities, and to examine the association between multi-morbidity burden and QOL while controlling for sociodemographic, clinical, ICD-related, and psychosocial variables.

Section snippets

Study design, sample, and data collection

All adults listed in the Swedish ICD and Pacemaker Registry in 2012 who had an ICD with or without cardiac resynchronization therapy (CRT-D) implanted for at least one year were invited to participate in this study [[16], [17], [18], [19]]. There were no further inclusion or exclusion criteria except willingness to participate and return the informed consent document. The Swedish ICD and Pacemaker Registry is a national database, in which patients with a cardiac implantable electronic device

Multi-morbidity burden

Researchers had no access to patients' medical records; therefore, information on comorbidities was obtained via a self-report questionnaire. Multi-morbidity has often been measured by a simple count of multi-morbid conditions or a weighted count that consider the severity of each condition in the overall burden score [20], the latter was the case in our study. Our questionnaire listed 14 significant, common comorbidities (e.g., heart failure, diabetes, and cancer) for which participants

Statistical analyses

All statistical analyses were completed using SPSS version 22 (IBM Corp., Armonk, NY, USA). Characteristics were compared between categories of multi-morbidity based on quartile measurements in the sample (≤16; 17–19; 20–22; and ≥ 23) using X2 and ANOVA with post-hoc Bonferroni adjustment. The prevalence of anxiety and depressive symptoms, Type-D personality, and ICD-related concerns were compared between the four comorbidity burden groups.

We initially attempted multiple linear regression, but

Background characteristics

Of the 5535 ICD recipients invited to participate, 3067 responded for a 55% response rate for all ICD recipients in Sweden. Of these, 2658 had data on the variables used in this analysis (Table 1). There was no way to determine the number of invited individuals who died between the time of implant and the time of data collection. The mean age of the respondents was 65 ± 12 years with a range of 19–94 years of whom 20.6% were female. Time since implantation ranged from one to 23 years with a

Discussion

Our results indicate that greater multi-morbidity burden is associated with lower QOL, which echoes the findings of studies in the general population [14,39,40]. Multi-morbidity affects multiple dimensions of QOL (e.g., physical, psychological, and social). A systematic review of studies for which QOL was the main outcome measure included seven international studies that indicated the negative impact of multi-morbidity on QOL [14]. All of the reported studies noted this relationship,

Conclusions

The ICD is considered as a lifesaving/extending device, yet there are important psychological ramifications with a significant impact on overall QOL and clinical outcomes that should be discussed and considered prior to device implantation, particularly in recipients with multi-morbid conditions. The presence of psychological distress should be monitored and treated in these patients during all phases of device therapy. There is currently an opportunity for improvement in the recognition and

Funding

This work was supported by grants from the Medical Research Council of Southeast Sweden (FORSS).

Declarations of interest

None.

References (72)

  • D. De Smedt et al.

    Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients

    Int. J. Cardiol.

    (2013)
  • D. De Smedt et al.

    Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey

    Int. J. Cardiol.

    (2013)
  • S.S. Pedersen et al.

    Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks

    Am. Heart J.

    (2005)
  • K. Dharmarajan et al.

    Multimorbidity in older adults with heart failure

    Clin. Geriatr. Med.

    (2016)
  • D.L. Carroll et al.

    Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock

    Heart Lung

    (2005)
  • S.F. Sears et al.

    Predictors of quality of life in patients with implantable cardioverter defibrillators

    Psychosomatics

    (2005)
  • C.M. Dougherty et al.

    Description of a nursing intervention program after an implantable cardioverter defibrillator

    Heart Lung

    (2004)
  • K.R. Kalbfleisch et al.

    Reemployment following implantation of the automatice cardioverter defibrillator

    Am. J. Cardiol.

    (1989)
  • K.C. Van den Broek et al.

    The distressed (Type D) personality in both patients and partners enhances the risk of emotional distress in patients with an implantable cardioverter defibrillator

    J. Affect. Disord.

    (2011)
  • G. Magyar-Russell et al.

    The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review

    J. Psychosom. Res.

    (2011)
  • J.M. Castellanos et al.

    Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey

    Heart Rhythm.

    (2012)
  • D.P. Zipes et al.

    A comparison of anti-arrythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrythmias

    N. Engl. J. Med.

    (1997)
  • G.H. Bardy et al.

    Amiodarone or implantable cardioverter defibrillator for congestive heart failure

    N. Engl. J. Med.

    (2005)
  • P.E. Vardas et al.

    Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

    Eur. Heart J.

    (2007)
  • A.S. Go et al.

    Heart disease and stroke statistics–2014 update: a report from the American Heart Association

    Circulation

    (2014)
  • H.G. Mond et al.

    The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009—a World Society of Arrhythmia's project

    Pacing Clin. Electrophysiol.

    (2011)
  • M.T. Hoogwegt et al.

    Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator

    Europace

    (2013)
  • A. Marengoni

    Prevalence and Impact of Chronic Diseases and Multimorbidity in the Aging Population: A Clinical and Epidemiological Approach

    (2008)
  • M. Fortin et al.

    Multimorbidity and quality of life in primary care: a systematic review

    Health Qual. Life Outcomes

    (2004)
  • D.A. Theuns et al.

    The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality

    Europace

    (2011)
  • C. Brettschneider et al.

    Relative impact of multimorbid chronic conditions on health-related quality of life—results from the MultiCare Cohort Study

    PLoS One

    (2013)
  • A. Stromberg et al.

    ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end of life

    Pacing Clin. Electrophysiol.

    (2014)
  • I. Thylen et al.

    Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes, and knowledge in end of life in patients living with an implantable cardioverter defibrillator

    Eur. J. Cardiovasc. Nurs.

    (2013)
  • C. Diedrichs et al.

    The measurement of multiple chronic diseases: a systematic review on existing multimorbidity indices

    J. Gerontol.

    (2011)
  • A.L. Huntley et al.

    Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide

    Ann. Fam. Med.

    (2012)
  • M.E. Salive

    Multimorbidity in older adults

    Epidemiol. Rev.

    (2013)
  • Cited by (11)

    View all citing articles on Scopus
    View full text